Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry StudyTessa Straatmijer, Joep Grootjans, Annemarie de Vries et al.|Clinical Gastroenterology and Hepatology|2022Cited by 51
Prospective real-world experience with risankizumab in difficult-to-treat Crohn’s disease: results from the Dutch Initiative on Crohn and Colitis RegistryLoriane Marina Michèle Verleye, Tessa Straatmijer, Marieke J Pierik et al.|Inflammatory Bowel Diseases|2026Cited by 0